Hyltoft-Petersen P - Search Results

1

Design of tumor biomarker-monitoring trials: a proposal by the European Group on Tumor Markers.

Sölétormos G, Duffy MJ, Hayes DF, Sturgeon CM, Barak V, Bossuyt PM, Diamandis EP, Gion M, Hyltoft-Petersen P, Lamerz RM, Nielsen DL, Sibley P, Tholander B, Tuxen MK, Bonfrer JM. Sölétormos G, et al. Among authors: hyltoft petersen p. Clin Chem. 2013 Jan;59(1):52-9. doi: 10.1373/clinchem.2011.180778. Epub 2012 Oct 3. Clin Chem. 2013. PMID: 23034139

2

Progression criteria for cancer antigen 15.3 and carcinoembryonic antigen in metastatic breast cancer compared by computer simulation of marker data.

Sölétormos G, Hyltoft Petersen P, Dombernowsky P. Sölétormos G, et al. Clin Chem. 2000 Jul;46(7):939-49. Clin Chem. 2000. PMID: 10894837

3

Valid analytical performance specifications for combined analytical bias and imprecision for the use of common reference intervals.

Hyltoft Petersen P, Lund F, Fraser CG, Sandberg S, Sölétormos G. Hyltoft Petersen P, et al. Ann Clin Biochem. 2018 Sep;55(5):612-615. doi: 10.1177/0004563217752963. Epub 2018 Jan 30. Ann Clin Biochem. 2018. PMID: 29310466

4

A dynamic reference change value model applied to ongoing assessment of the steady state of a biomarker using more than two serial results.

Lund F, Hyltoft Petersen P, Fraser CG. Lund F, et al. Among authors: hyltoft petersen p. Ann Clin Biochem. 2019 Mar;56(2):283-294. doi: 10.1177/0004563219826168. Epub 2019 Feb 25. Ann Clin Biochem. 2019. PMID: 30803249

5

Interpretation of serial measurements of international normalized ratio for prothrombin times in monitoring oral anticoagulant therapy.

Lassen JF, Kjeldsen J, Antonsen S, Hyltoft Petersen P, Brandslund I. Lassen JF, et al. Clin Chem. 1995 Aug;41(8 Pt 1):1171-6. Clin Chem. 1995. PMID: 7628093

6

Evidence for a substantial genetic influence on biochemical liver function tests: results from a population-based Danish twin study.

Bathum L, Petersen HC, Rosholm JU, Hyltoft Petersen P, Vaupel J, Christensen K. Bathum L, et al. Clin Chem. 2001 Jan;47(1):81-7. Clin Chem. 2001. PMID: 11148181

7

Improved RNase protection assay for quantifying LDL-receptor mRNA; estimation of analytical imprecision and biological variance in peripheral blood mononuclear cells.

Petersen NE, Larsen LK, Nissen H, Jensen LG, Jensen A, Hyltoft Petersen P, Hørder, Gregersen N, Kristiansen K. Petersen NE, et al. Clin Chem. 1995 Nov;41(11):1605-13. Clin Chem. 1995. PMID: 7586550

8

Creation of a low-risk reference group and reference interval of fasting venous plasma glucose.

Jørgensen LG, Brandslund I, Hyltoft Petersen P, Stahl M, de Fine Olivarius N. Jørgensen LG, et al. Among authors: hyltoft petersen p. Clin Chem Lab Med. 2004;42(7):817-23. doi: 10.1515/CCLM.2004.135. Clin Chem Lab Med. 2004. PMID: 15327018

9

Robust nonradioactive oligonucleotide ligation assay to detect a common point mutation in the CYP2D6 gene causing abnormal drug metabolism.

Hansen TS, Petersen NE, Iitiä A, Blaabjerg O, Hyltoft-Petersen P, Hørder M. Hansen TS, et al. Clin Chem. 1995 Mar;41(3):413-8. Clin Chem. 1995. PMID: 7882517

10

Graphical interpretation of confidence curves in rankit plots.

Hyltoft Petersen P, Blaabjerg O, Andersen M, Jørgensen LG, Schousboe K, Jensen E. Hyltoft Petersen P, et al. Clin Chem Lab Med. 2004;42(7):715-24. doi: 10.1515/CCLM.2004.122. Clin Chem Lab Med. 2004. PMID: 15327005 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page